Phoebe WilsonHospital admissions in England linked to Covid-19 rose by nearly 50% in a single week in early October 2026, driven by a newly dominant strain that originated in the United States. The XFG variant — widely nicknamed "American Covid" — carries a symptom that sets it apart from every previous wave: a distinctive hoarseness that thousands of UK residents are dismissing as a winter sore throat. Health experts say this delay is costing some patients their window for early treatment.
What Is the "American Covid" XFG Strain?
The XFG variant, officially listed by the World Health Organisation as a variant under monitoring, first emerged from genetic surveillance in the United States in early 2025 before spreading internationally. It belongs to the Omicron lineage but carries a distinct mutation cluster that gives it a replication advantage in upper respiratory tissues — specifically the larynx and vocal cords.
Unlike the BA.3.2 "Cicada" variant that circulated earlier in 2026, XFG (also referred to by researchers as "Stratus") does not necessarily produce the razor-sharp sore throat that defined winter. Instead, XFG inflames the larynx in a way that mimics laryngitis, causing many people to suspect they have strained their voice at work or caught a common cold rather than Covid.
London has seen the sharpest increase in the current wave, with Covid-related hospital admissions rising by almost 80% in seven days, according to NHS data reported in October 2026. The UK Health Security Agency has confirmed XFG as the dominant circulating strain across England.
The Hoarse Voice: A Symptom Worth Taking Seriously
Pharmacists and GPs reporting on XFG consistently highlight a single early distinguishing feature: hoarseness or a raspy, scratchy quality to the voice, often appearing before any cough or fever. In many cases it is the first and only symptom for the initial 24 to 48 hours, which is why so many people attribute it to talking too much, a draughty commute, or the start of a generic winter bug.
The full symptom profile of XFG, in order of clinical frequency, includes:
- Hoarseness or raspy, scratchy voice — the hallmark, often first to appear
- Dry cough — typically less productive than in earlier strains
- Sore throat — moderate rather than the severe "razor blade" pain of Cicada
- Fatigue — described by many patients as a cloudy, heavy tiredness
- Fever or chills — present in roughly half of confirmed cases
- Muscle aches — particularly in the back and upper arms
- Loss of taste or smell — less common than in earlier strains, but still reported
Two classic markers have largely disappeared from XFG: the spike fever above 39°C that defined the original strain, and the profound smell loss that characterised Delta. Most XFG infections stay in the upper respiratory tract, which explains both the lower perceived severity and the high transmission rate — people feel well enough to continue their routines and carry the virus with them.
Why the 50% Admissions Jump Is a Warning
If the majority of XFG cases remain mild, why are hospital admissions climbing so steeply? The answer lies in who is most exposed to the current wave. A combination of waning immunity, a new mutation profile, and the approach of autumn indoor socialising has created ideal conditions for XFG to break through in groups that previously had strong protection.
Hospital admissions are being driven primarily by adults over 65 with underlying health conditions, immunocompromised individuals, and those with pre-existing respiratory conditions such as asthma or COPD. For these groups, a presentation that begins with hoarseness and mild fatigue can escalate to lower respiratory involvement within 72 hours, sometimes faster.
The NHS advises that anyone experiencing difficulty breathing, persistent chest pain, confusion, or bluish-tinged lips should call 999 immediately. But the critical issue highlighted by health professionals is the narrow treatment window that exists before those red-flag symptoms appear.
Antiviral treatments, including nirmatrelvir/ritonavir (Paxlovid), remain available on prescription for eligible high-risk patients through the NHS Covid Treatment National Protocol. They are clinically effective — but must be started within five days of first symptom onset to work. That five-day window begins with the first hoarse morning, not with the fever that follows three days later.
How Two Days Changed Everything for a Bristol Pensioner
Consider a 67-year-old retired engineer — call him David — living in Bristol with well-controlled type 2 diabetes. In late September 2026, he noticed his voice sounding rough and assumed he had been talking too much at a family gathering. He felt tired but not unwell. No fever, no cough, no obvious alarm.
On day three, he developed a mild temperature of 37.9°C and took paracetamol. On day four, a family member persuaded him to take a lateral flow test: positive for Covid.
By day five, his breathing had become laboured. He was admitted to Southmead Hospital and spent four days on supplemental oxygen before being discharged with a six-week recovery plan.
If David had consulted a GP or online health expert on day one or two — when the hoarseness and fatigue first appeared — a clinician could have assessed his eligibility for Paxlovid immediately. As a diabetic man over 65, David met the NHS criteria for antiviral treatment without question. The five-day course costs the NHS approximately £450.
The if/then outcome: if treatment had started on day two, David's risk of progressing to severe illness would have been meaningfully reduced within the clinically validated window. Instead, a four-day hospitalisation — costing the NHS an average of £3,200 per admission according to NHS Improvement reference costs — became the outcome. For David personally, beyond the financial calculation: six weeks of limited activity, and, as he later described it, "a level of fear I'd never quite had before."
The difference between those two paths was 48 hours and one expert consultation.
This is the pattern health experts say is repeating across England: people in high-risk groups attributing XFG's early hoarseness to something benign, losing the treatment window, and presenting to hospital when prevention was still possible days earlier.
Who Should Consult a Health Professional This Week
For healthy adults under 60 with no underlying conditions, XFG will typically resolve within 7 to 10 days with rest, fluids, and over-the-counter symptom management. Proactive expert consultation is not necessary for the general population with mild symptoms.
The groups for whom early consultation — ideally within 24 to 48 hours of first symptoms — is strongly recommended are:
- Adults aged 65 and over, regardless of vaccination status
- Anyone with a weakened immune system (active cancer treatment, organ transplant recipients, long-term steroid use, HIV)
- Pregnant women
- Anyone with severe or uncontrolled asthma, COPD, or chronic heart disease
- Adults with type 1 or type 2 diabetes
- Anyone who lives with a person in one of the above categories and is symptomatic
For these groups, the five-day antiviral window is the governing logic. The clock starts from the first symptom — not from the positive test, and not from when symptoms feel serious. Waiting to see whether things improve is a reasonable instinct for a healthy thirty-year-old; for a 68-year-old with cardiac disease, it can mean the difference between a phone consultation and an admission.
Online health platforms allow eligible patients to speak with a registered GP or health professional without attending a surgery — which is especially important when XFG's high transmissibility makes waiting rooms a risk for both the patient and others.
The Practical Checklist for This Week
If you develop a hoarse voice, unusual fatigue, or any combination of the XFG symptoms listed above in October 2026:
- Test — a lateral flow test taken from day two of symptoms gives the clearest reading. A positive result immediately changes what help you are eligible for.
- Isolate — even if you feel well. XFG circulates during the early hoarse phase when many people feel capable of their normal routines.
- Check your risk profile — if you are over 65, immunocompromised, pregnant, or have a relevant underlying condition, contact a health professional within 48 hours.
- Don't wait for severity — the threshold for seeking expert advice is the first symptom if you are high-risk, not the arrival of a high fever.
- Know the 999 signs — difficulty breathing, persistent chest pressure, confusion, or blue-tinged lips warrant an emergency call regardless of other factors.
The broader picture from XFG — consistent with what health professionals have been noting about new and emerging diseases circulating in the UK — is that the line between mild and serious is lower and faster to cross for vulnerable groups than the general population tends to assume.
The hoarse voice is not just a scratchy throat. This autumn, it is a five-day clock starting.
This article is for informational purposes only and does not constitute medical advice. If you are experiencing symptoms of Covid-19 or any other illness, consult a qualified health professional.
